Development of mRNA Vaccine Candidates for Pandemic Influenza
Time: 11:15 am
day: Day 2 Track 1 AM
Details:
- Optimising design of different HA candidates
- Unravelling in vivo proof of concept data for an mRNA influenza vaccine
- Demonstrating scaling up and process development methods
